RAC/CDC42 INHIBITORS AS NEW DRUGS FOR PANCREATIC CANCER
Project description: Demonstrate the efficacy of Rac/Cdc42 inhibitors as new drugs for pancreatic cancer using pancreatic cancer mouse models, and the effect on tumor microenvironment from pancreatic cancer patient’s tissue.
